To amend the Internal Revenue Code of 1986 to provide a credit against tax for expenses paid or incurred in non-clinical research for neglected diseases.

H.R. 3156 Neglected Disease Tax Credit Bill P.L. 111-148 Patient Protection and Affordable Care Act P.L. 111-152 Health Care and Education Reconciliation Act of 2010 S. 3677 Financial Services and General Government Appropriations Act, 2011 (Pay to Delay Provision)

Client expense: Not reported · Firm income: $80,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156, Neglected Disease Tax Credit Bill H.R. 759, Food and Drug Administration Globalization Act of 2009 P.L. 111-148, Patient Protection & Affordable Health Care Act Treatment of Orphan Drugs Under 340B Expansion P.L. 111-152, Health Care and Education Reconciliation Act of 2010 H.R. 3081, Continuing Appropriations Act of 2011 (340B Provisions)

Client expense: $660,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

H.R. 3156, Neglected Disease Tax Credit Bill Excise Tax for Medical Devices P.L. 111-148, Patient Protection & Affordable Health Care Act Excise Tax for Drugs and Biologics P.L. 111-152, Health Care and Education Reconciliation Act of 2010

Client expense: $660,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of

Public Health Programs for Infectious and Tropical Disease; Issues related to Neglected Disease Product Approval; S. 624 - Water for the World Act of 2009; H.R. 3156 - A Bill to Provide Tax Credits for Research for Neglected Tropical Diseases; H.R. 5986 - Neglected Infections of Impoverished Americans Act.

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID)

H.R. 3156, Neglected Disease Tax Credit Bill Excise Tax for Medical Devices H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 H.R. 3590, Patient Protection & Affordable Health Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010

Client expense: $680,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

H.R. 3156, Neglected Disease Tax Credit Bill H.R. 759, Food and Drug Administration Globalization Act of 2009 H.R. 3590, Patient Protection & Affordable Health Care Act Treatment of Orphan Drugs Under 340B Expansion H.R. 4872, Health Care and Education Reconciliation Act of 2010

Client expense: $680,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE

Public Health Programs for Infectious and Tropical Disease S. 624 - Water for the World Act of 2009 H.R. 3156 - A Bill to Provide Tax Credits for Research for Neglected Tropical Diseases

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID)

H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156 Neglected Disease Tax Credit Bill H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156, Neglected Disease Tax Credit Bill Excise tax for laboratory tests Excise tax for drugs Excise tax for medical devices H.R. 3200, America's Affordable Health Choices Act of 2009 H.R. 3962, Affordable Health Care for Americans Act H.R. 3590, Patient Protection & Affordable Health Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010

Client expense: $712,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1548, Pathway for Biosimilars Act of 2009 H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act S. 726, Promoting Innovation and Access to Life-Saving Medicines Act S. 301, Physician Payments Sunshine Act of 2009 H.R. 3156, Neglected Disease Tax Credit Bill H.R. 1298, Pharmaceutical Market Access & Drug Safety Act of 2009" - Importation. S.525, "Pharmaceutical Market Access & Drug Safety Act of 2009" - Importation H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 1679, America's Affordable Health Choices Act of 2009 H.R. 3962, Affordable Health Care for Americans Act H.R. 3590, Patient Protection & Affordable Health Care Act Treatment of Orphan Drugs Under 340B Expansion H.R. 4872, Health Care and Education Reconciliation Act of 2010

Client expense: $712,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156 Neglected Disease Tax Credit Bill H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010

Client expense: Not reported · Firm income: $90,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Public Health Programs for Infectious and Tropical Disease S. 624 - Water for the World Act of 2009 H.R. 3156 - A Bill to Provide Tax Credits for Research for Neglected Tropical Diseases

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID)

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $120,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $120,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156, Neglected Disease Tax Credit Bill Excise Tax for laboratory tests Excise Tax for drugs Excise Tax for medical devices House Tri-Caucus Health Reform Bill Senate Finance Health Reform Bill H.R. 3200, America's Affordable Health Choices Act of 2009 H.R. 3962, Affordable Health Care for Americans Act H.R. 3590, Patient Protection & Affordable Health Care Act

Client expense: $750,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1548, Pathway for Biosimilars Act of 2009 H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act S. 726 Promoting Innovation and Access to Life-Saving Medicines Act S. 301 Physician Payments Sunshine Act of 2009 H.R. 3156, Neglected Disease Tax Credit Bill H.R. 1298, Pharmaceutical Market Access & Drug Safety Act of 2009" - Importation. S.525, "Pharmaceutical Market Access & Drug Safety Act of 2009" - Importation H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 1679, America's Affordable Health Choices Act of 2009 House Tri-Caucus Health Reform Bill H.R. 3962, Affordable Health Care for Americans Act H.R. 3590, Patient Protection & Affordable Health Care Act Treatment of Orphan Drugs Under 340B Expansion

Client expense: $750,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Public Health Programs for Infectious and Tropical Disease S. 624 - Water for the World Act of 2009 H.R. 3156 - A Bill to Provide Tax Credits for Research for Neglected Tropical Diseases

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID)

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $120,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $120,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 3156, Neglected Disease Tax Credit Bill Excise Tax for laboratory tests Excise Tax for drugs Excise Tax for medical devices House Tri-Caucus Health Reform Bill Senate Finance Health Reform Bill H.R. 3200, America's Affordable Health Choices Act of 2009

Client expense: $900,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1548, Pathway for Biosimilars Act of 2009 H.R. 1427, Promoting Innovation and Access to Life-Saving Medicines Act S. 726 Promoting Innovation and Access to Life-Saving Medicines Act S. 301 Physician Payments Sunshine Act of 2009 H.R. 3156, Neglected Disease Tax Credit Bill Neglected Disease Issues Issues related to Drug Safety, Generic Biologics & Drug Approvals Importation. H.R. 1298, Pharmaceutical Market Access & Drug Safety Act of 2009" - Importation. S.525, "Pharmaceutical Market Access & Drug Safety Act of 2009" - Importation H.R. 759, Food and Drug Administration Globalization Act of 2009

Client expense: $900,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $130,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3156 Neglected Disease Tax Credit Bill

Client expense: Not reported · Firm income: $130,000

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Public Health Programs for Infectious and Tropical Disease S. 624 - Water for the World Act of 2009 H.R. 3156 - A Bill to Provide Tax Credits for Research for Neglected Tropical Diseases

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Disease Control & Prevention (CDC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, U.S. Agency for International Development (USAID)